{"id":2930,"date":"2021-06-29T08:56:23","date_gmt":"2021-06-29T08:56:23","guid":{"rendered":"https:\/\/www.scin.scot.nhs.uk\/?page_id=2930"},"modified":"2025-10-29T16:48:35","modified_gmt":"2025-10-29T16:48:35","slug":"pet-ct-guidelines","status":"publish","type":"page","link":"https:\/\/www.nn.nhs.scot\/scin\/professional\/scin-work\/scin-pet-ct\/pet-ct-guidelines\/","title":{"rendered":"PET-CT Guidelines"},"content":{"rendered":"\n<p>Guidelines for the use of PET-CT scanning approved for NHS Scotland by the Scottish Clinical Imaging Network (SCIN) PET-CT working group are available below:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2022\/03\/GUIDELINES-OVERVIEW-INDICATIONS-FOR-THE-USE-OF-PET-CT-IN-SCOTLAND.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2024\/02\/NSD610-005.01-SCIN-INDICATIONS-FOR-THE-USE-OF-18F-FDG-PET-CT-IN-LYMPHOMA.pdf\">PET-CT Scanning in the management of patients with Lymphoma<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2014\/11\/cropped-SCIN_logo_final-2-1.jpg\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.nn.nhs.scot\/scin\/wp-content\/uploads\/sites\/14\/2025\/10\/NSD.610-005.02-INDICATIONS-FOR-USE-OF-18F-FDG-PETCT-IN-THE-MANAGEMENT-OF-PATIENTS-WITH-COLORECTAL-CANCER-2025.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">PET-CT Scanning in the management of patients with Colorectal Cancer<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2014\/11\/cropped-SCIN_logo_final-2-1.jpg\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2024\/02\/NSD610-005.03-SCIN-INDICATIONS-FOR-THE-USE-OF-PSMA-PET-CT-IN-PROSTATE-CANCER-PATIENTS.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Clinical indications for the use of 68GALLIUM PSMA PET-CT in Prostate Cancer patients<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2014\/11\/cropped-SCIN_logo_final-2-1.jpg\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2024\/02\/NSD610-005.04-SCIN-INDICATIONS-FOR-THE-USE-OF-18F-FDG-PETCT-IN-OESOPHAGEAL-AND-OESOPHAGOGASTRIC-JUNCTION-OGJ-CANCER.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Clinical indications for the use of 18F-FDG PET-CT in Oesophageal &amp; Oesophagogastric Junction Cancer<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2014\/11\/cropped-SCIN_logo_final-2-1.jpg\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2024\/02\/NSD610-005.05-SCIN-INDICATIONS-FOR-THE-USE-OF-18F-FDG-PET-CT-IN-LUNG-CANCER-IN-SCOTLAND.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Clinical indications for the use of 18F-FDG PET-CT in Lung Cancer in Scotland<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2014\/11\/cropped-SCIN_logo_final-2-1.jpg\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.nn.nhs.scot\/wp-content\/uploads\/2025\/10\/NSD610-005.06-INDICATIONS-FOR-THE-USE-OF-18F-FDG-PET-CT-IMAGING-IN-THE-MANAGEMENT-OF-HEAD-AND-NECK-CANCER-2025.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Clinical indications for the use of 18F-FDG PET-CT imaging in the management of Head &amp; Neck Cancer<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2014\/11\/cropped-SCIN_logo_final-2-1.jpg\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.nn.nhs.scot\/scin\/wp-content\/uploads\/sites\/14\/2025\/10\/NSD.610-005.07-Indications-for-the-use-of-18F-FDG-PET-CT-in-the-management-of-gynaecological-cancer-2025.pdf\">Clinical indications for the use of 18F-FDG PET-CT in the management of Gynaecological Cancer<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2014\/11\/cropped-SCIN_logo_final-2-1.jpg\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.nn.nhs.scot\/wp-content\/uploads\/2025\/10\/NSD.610-005.08-Indications-for-the-use-of-68Ga-DOTA-PET-CT-in-Neuroendocrine-Tumours-2025.pdf\">Clinical indications for the use of 68GALLIUM DOTA PET-CT (68Ga DOTA) in Neuroendocrine Tumours<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2023\/12\/NSD610-005.09-SCIN-IndicatorsPETCT-IMAGING-IN-VASCULITIS.pdf\">Clinical indications for the use of 18F FDG PET-CT Imaging in Vasculitis<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2014\/11\/cropped-SCIN_logo_final-2-1.jpg\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.nn.nhs.scot\/wp-content\/uploads\/2025\/10\/NSD610-005.10-INDICATIONS-FOR-THE-USE-OF-18F-FDG-PET-CT-IN-BREAST-CANCER-PATIENTS-IN-SCOTLAND-2025.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Clinical indications for the use of 18F FDG PET-CT in Breast Cancer patients in Scotland<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2014\/11\/cropped-SCIN_logo_final-2-1.jpg\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2023\/12\/NSD610-005.11-SCIN-MALIGNANT-MELANOMA.pdf\">Clinical indications for the use of 18F FDG PET-CT malignant melanoma in Scotland<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2014\/11\/cropped-SCIN_logo_final-2-1.jpg\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2023\/12\/NSD610-005.14-SCIN-PET-SARCOMA-PATIENTS-AND-GASTROINTESTINAL.pdf\">Clinical indications for the use of FDG PET-CT Imaging in the management of sarcoma patients and gastrointestinal stromal tumours<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2014\/11\/cropped-SCIN_logo_final-2-1.jpg\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2023\/12\/NSD610-005.13-SCIN-PET-CT-IN-PANCREATIC.pdf\">Clinical Indications for the use of 18F FDG PET-CT in pancreatic and hepatobiliary cancer<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2021\/10\/NSD610-005.12.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><a href=\"https:\/\/www.scin.scot.nhs.uk\/wp-content\/uploads\/sites\/14\/2023\/12\/NSD610-005.12-SCIN-Patients-with-brain-tumours-in-scotland.pdf\">Clinical indications for the use of 18F FDG PET-CT for patients with brain tumours in Scotland<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p class=\"nhsuk-card__description\">Guidelines for the use of PET-CT scanning approved for NHS Scotland by the Scottish Clinical Imaging Network (SCIN) PET-CT working [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":0,"parent":49,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2930","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.nn.nhs.scot\/scin\/wp-json\/wp\/v2\/pages\/2930","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nn.nhs.scot\/scin\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.nn.nhs.scot\/scin\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scin\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scin\/wp-json\/wp\/v2\/comments?post=2930"}],"version-history":[{"count":88,"href":"https:\/\/www.nn.nhs.scot\/scin\/wp-json\/wp\/v2\/pages\/2930\/revisions"}],"predecessor-version":[{"id":3854,"href":"https:\/\/www.nn.nhs.scot\/scin\/wp-json\/wp\/v2\/pages\/2930\/revisions\/3854"}],"up":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scin\/wp-json\/wp\/v2\/pages\/49"}],"wp:attachment":[{"href":"https:\/\/www.nn.nhs.scot\/scin\/wp-json\/wp\/v2\/media?parent=2930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}